New Year, New Milestone – Another Prestigious Certification Achieved!

Sunrise Pharmaceutical Co., Ltd. Successfully Passes the China Veterinary Drug GMP Re-inspection.

Rigorous Review, Full Compliance Achieved

During the two-day on-site inspection, the expert panel strictly followed veterinary drug GMP standards and conducted a comprehensive review across all dimensions, including production sites, facilities and equipment, quality control, and system operations.

The final assessment: Sunrise Pharmaceutical's veterinary drug production lines are certified as GMP-compliant production lines.

14 Years of Commitment, Uncompromising Quality

Since first passing the veterinary drug GMP inspection in 2012, Sunrise Pharmaceutical has continuously optimized its GMP management system for 14 consecutive years, embedding compliance control and quality-first principles throughout the entire production process.

Premium Credentials – Dual Certifications

Sunrise Pharmaceutical specializes in the R&D and production of veterinary drug APIs and formulations, and has obtained:

• EU Veterinary Drug GMP Certification

• China Veterinary Drug GMP Certification

• ISO 9001:2015 Quality Management System Certification

Premium Products, Trusted Worldwide

Our core offerings include Azamethiphos APIs and formulations, widely used in global salmon farming and public health insect control. Our fish drug formulations are exported to Europe, South America, and beyond. 3,6-Dichloropyridazine and other pharmaceutical and veterinary intermediates have earned the trust of customers both domestically and internationally through consistent quality. We also provide custom processing services that meet GMP standards.

Quality First, Win-Win Future

With compliance as our foundation and quality as our core,

Sunrise Pharmaceutical will continue to strengthen quality management and enhance product competitiveness.

We sincerely invite domestic and international partners to join us in exploring business opportunities and achieving mutual growth!